Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Omlyclo (omalizumab-igec), an Interchangeable Biosimilar to Xolair

Celltrion today announced the U.S. Food and Drug Administration (FDA) approved Omlyclo® (omalizumab-igec) as the first and only biosimilar...

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the Furoscix Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease

scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through...

FDA Approves Encelto (revakinagene taroretcel-lwey) for the Treatment of Macular Telangiectasia Type 2 (MacTel)

(BUSINESS WIRE)--Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative therapies for chronic eye diseases, announced...

Red Wine Protects Against Cancer? Maybe Not

Red wine has been thought to potentially offer protection against cancer, given its high levels of the anti-inflammatory antioxidant resveratrol.But there’s...

Weed Use During Pregnancy Triples Risk Of Behavioral Problems In Kids

Some women turn to weed during pregnancy to help deal with common issues like nausea, sleep problem and stress.Unfortunately, they could be endangering...

Concussion Damage Lingers In Athletes' Brains Up To A Year

Concussion damage could linger in an athlete’s brain for at least a year, long after they’ve rejoined their sport, a new study says.Concussed college...

Turning Off TV Better For Heart Health Of Folks Predisposed To Diabetes

People with a higher genetic risk for type 2 diabetes also have a higher risk of heart attack, stroke and other heart-related diseases.But controlling...

ViiV Healthcare’s Investigational Broadly Neutralising Antibody - N6LS - Successfully Maintains Viral Suppression in Long-Acting Treatment of HIV

London, 12 March 2025 – ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today...

Tecovirimat is Safe But Ineffective as Treatment for Clade II Mpox

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve pain control...

Bronchodilator Responsiveness Positivity More Likely in Morning

Patients are more likely to have positive bronchodilator responsiveness in the morning and in winter months, according to a study published online March...

AAOS: Header Ban Linked to Decrease in Soccer-Linked Concussions in Children

Introduction of the United States Soccer Federation (USSF) header ban for athletes aged 10 years and younger in 2015 was associated with a reduction in...

Minimal TV Viewing May Cut ASCVD Risk in Those With T2DM Genetic Risk

Medium and high type 2 diabetes (T2D) genetic risks are not associated with an increased risk for atherosclerotic cardiovascular disease (ASCVD) when television...

No Weight Loss Benefit Seen for Neoadjuvant Semaglutide Before Weight Loss Surgery

Neoadjuvant semaglutide before metabolic and bariatric surgery (MBS) is not beneficial in terms of weight loss, according to a research letter published...

Voluntary Lot Withdrawals of Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC) Due to Increased Reports of Allergic/Hypersensitivity Reactions

As a precautionary measure, the following lots of Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC) have been voluntarily withdrawn...

Butter Is A Deadly Delight, Study Says

It’s a cook’s maxim that everything’s better with butter. Except your health, a new study suggests. People who eat loads of butter...

Read more news...

Recently Added

Recently added consumer and prescribing information: Opdivo Qvantig, Alyftrek, Crenessity, Ensacove, Steqeyma, Yesintek, Revuforj, Danziten, Aucatzyl, Emrosi

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Omlyclo Omlyclo (omalizumab-igec) is an anti-IgE antibody interchangeable biosimilar to Xolair for the treatment of asthma, chronic rhinosinusitis...
  • Encelto Encelto (revakinagene taroretcel-lwey) is an allogeneic encapsulated cell-based gene therapy indicated for the treatment of adults with...
  • Osenvelt Osenvelt (denosumab-bmwo) is a RANK ligand (RANKL) inhibitor biosimilar to Xgeva (denosumab) for use in the prevention of skeletal-related...

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil tentatively approved for the treatment of pulmonary arterial...

More drugs in development